Exploring Rapamycin, Longevity and Healthspan with Dr. Matt Kaeberlein
Feb 9, 2024
auto_awesome
Dr. Matt Kaeberlein, CEO of OptiSpan and co-director of the Dog Aging Project, discusses the potential of rapamycin for longevity and healthspan. He explains the biological mechanisms, optimal dosing, and effects on the immune system. They also explore aging clocks, biomarkers, and the significance of the microbiome in aging research. Visit OptiSpan.life for more information.
Rapamycin has shown positive effects on longevity and organ function, particularly the immune system, when administered starting in middle age.
The lack of financial incentive for large clinical trials and concerns about immunosuppression present challenges to the research and acceptance of rapamycin as an anti-aging intervention.
While aging clocks and microbiome assessment hold promise for health evaluation, more comprehensive data and understanding are needed before their full potential can be realized.
Deep dives
The Benefits and Efficacy of Rapamycin in Aging
Rapamycin is considered the gold standard in longevity interventions due to its extensive preclinical studies that demonstrate increased lifespan and delayed aging in various model systems. Unlike many other interventions, rapamycin has consistently shown positive effects on longevity when administered starting in middle age. It has been observed to reverse functional declines in organs and tissues, such as the heart and immune system, within short periods of treatment. While the optimal dose for longevity is still uncertain, the widely used dose of six milligrams once a week in humans has been associated with improved immune response and reduced infection risk. However, caution is advised as higher doses and daily use may lead to side effects such as metabolic dysregulation and increased risk of infection.
The Challenges of Rapamycin Research and Implementation
The research and implementation of rapamycin face several challenges. One major challenge is the lack of financial incentive for large clinical trials due to rapamycin's off-patent status. Furthermore, rapamycin carries a black box warning due to its historical use at high doses in organ transplant patients, leading to side effects. Consequently, its reputation as an immunosuppressant makes it less appealing for widespread pharmaceutical research. However, recent studies suggest that at lower doses and in otherwise healthy individuals, rapamycin does not significantly suppress the immune system. Concerns about immunosuppression and the complexity of finding the optimal dose further complicate the research and acceptance of rapamycin as a potential anti-aging intervention.
The Potential of Biological Aging Clocks
Biological aging clocks, such as epigenetic clocks, have gained attention as tools to measure health and longevity. While these clocks have shown correlation with mortality risk or disease outcomes, they have limitations in terms of unbiased replication and validating their accuracy across diverse populations and changing environments. Moreover, the lack of standardized quality control in the direct-to-consumer market raises concerns about the reliability of these clocks. Instead, focusing on established markers of health, such as comprehensive blood biomarkers and physical assessments, may provide more actionable insights into improving health span and preventing age-related diseases.
Benefits of Rapamycin on Joint Pain and Muscle Growth
One main point discussed in the podcast is the potential benefits of rapamycin on joint pain and muscle growth. The speaker shares their personal experience of using rapamycin to alleviate joint pain during weightlifting and suggests that rapamycin may have a positive impact on recovery from injuries and muscle synthesis. Animal studies mentioned also indicate that rapamycin treatment can protect against muscle loss in the context of aging. While the direct impact of rapamycin on muscle growth during resistance training has yet to be studied, anecdotal evidence suggests that rapamycin may aid in body composition changes, making it easier to lose fat mass and retain lean mass.
The Use of Aging Clocks and Microbiome for Health Assessment
Another main point discussed in the podcast is the use of aging clocks and microbiome assessment for health evaluation. The speaker acknowledges the potential of aging clocks, such as epigenetic clocks, in predicting mortality and establishing personalized nutrition plans. However, they express skepticism about the individual applicability and predictability of these clocks in assessing response to interventions. Similarly, regarding the microbiome, the speaker recognizes its importance but highlights the complexity and lack of actionable data at present. They emphasize the need for further research to understand the impacts of the microbiome on individual health risks, nutritional strategies, and early disease detection. Overall, while these assessments show promise, more comprehensive data and understanding are required to fully leverage their potential for personalized health optimization.
In this episode, Dr. Matt Kaeberlein, CEO of OptiSpan and co-director of the Dog Aging Project, and Joe explore the fascinating realm of rapamycin and its implications for longevity and healthspan.
Dr. Kaeberlein delves into the biological mechanisms underlying rapamycin's effects, the best way to take it, and its impact on immune system processes.
Gain insights from Dr. Kaeberlein's research on the mTor mechanism and rapamycin, uncovering their promising potential in extending healthspan and enhancing lifespan.
Finally, Matt and Joe discuss aging clocks, biomarkers, and microbiome tests, evaluating their significance in the context of aging research and longevity enhancement.